{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:25Z","timestamp":1788415945557,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Heart failure (HF) and chronic kidney disease (CKD) frequently coexist and share chronic low-grade inflammation, oxidative stress, and thrombotic activation. Natriuretic peptides remain the cornerstone of HF prognostication, but their interpretation is confounded by reduced renal clearance, leading to false elevations and attenuated prognostic specificity in CKD. The systemic immune-inflammation index (SII), derived from routine blood counts, integrates neutrophil-driven inflammation, lymphocyte-mediated immunity, and platelet-associated thrombosis, and may provide a renal-function\u2013independent adjunct to natriuretic peptides among patients with non-dialysis CKD. We aimed to evaluate whether SII provides incremental prognostic information to BNP and NT-proBNP in HF, with particular attention to the non-dialysis cardiorenal spectrum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a two-cohort study. The derivation cohort included 1,284 adults hospitalized for chronic HF at Guangdong Medical University Affiliated Hospital (2018\u20132023). The external validation cohort comprised adults with a first HF hospitalization from MIMIC-IV v3.1 (2008\u20132022). After excluding patients without SII data and those with incomplete covariates, 11,767 patients were included in the primary analysis. The systemic immune-inflammation index (SII), a composite inflammatory marker derived from routine complete blood count, was calculated as platelet count (\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L) \u00d7 neutrophil count (\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L) \/ lymphocyte count (\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L). Patients were stratified by CKD-EPI estimated glomerular filtration rate (eGFR) into &amp;gt;=60, 30\u201359, and &amp;lt;30 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . Cox proportional hazards regression, C-index comparisons, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and SII \u00d7 CKD-stage interaction tests were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SII predicted mortality in the derivation cohort (HR 1.012, 95% CI 1.007\u20131.017,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20097.5\u2009\u00d7\u200910\u207b\u2076) and added modest incremental value to NT-proBNP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SII is an inexpensive, universally available prognostic marker in HF patients with non-dialysis CKD. It does not replace NT-proBNP, but provides a statistically significant yet clinically modest incremental signal in CKD\u2014across the non-dialysis CKD spectrum. SII may serve as a practical adjunct, not a substitute, for risk stratification across the non-dialysis cardiorenal spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1928233","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:13Z","timestamp":1788412453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic immune-inflammation index as a prognostic marker in heart failure with non-dialysis chronic kidney disease: a two-cohort derivation and validation study with head-to-head comparison against natriuretic peptides"],"prefix":"10.3389","volume":"13","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University, Jinan University","place":["Guangzhou, China"]},{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University, The First Huizhou Affiliated Hospital of Guangdong Medical University","place":["Huizhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University, Jinan University","place":["Guangzhou, China"]},{"name":"Department of Cardiology, Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1161\/CIR.0000000000000744","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"141","author":"Kurz","year":"2020","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the PRIDE study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2006.07.001","article-title":"Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?","volume":"48","author":"Van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12872-023-03572-6","article-title":"Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure: a systematic review and meta-analysis","volume":"23","author":"Vakhshoori","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25835","DOI":"10.1038\/s41598-024-83583-1","article-title":"Platelet-to-lymphocyte ratio is associated with in-hospital mortality in ICU patients with heart failure","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/JIR.S451190","article-title":"The associations of two novel inflammation biomarkers, SIRI and SII, with mortality risk in patients with chronic heart failure","volume":"17","author":"Zhu","year":"2024","journal-title":"J Inflamm Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3760\/cma.j.issn.0253-3758.2018.10.004","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2018","volume":"46","year":"2018","journal-title":"Chin J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1161\/01.CIR.101.23.e215","article-title":"Physiobank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals","volume":"101","author":"Goldberger","year":"2000","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"B23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1214\/ss\/1177013815","article-title":"Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy","volume":"1","author":"Efron","year":"1986","journal-title":"Stat Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"B28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"B29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0735-1097(03)00163-3","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals","volume":"41","author":"Fried","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ahj.2014.07.010","article-title":"Interleukin-6 as a predictor of adverse outcomes in chronic heart failure","volume":"168","author":"Van Tassell","year":"2014","journal-title":"Am Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e13230","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/ijms23073793","article-title":"Investigation of the associations of novel inflammatory biomarkers\u2014systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI)\u2014with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/07853890.2022.2082917","article-title":"Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"54","author":"Han","year":"2022","journal-title":"Ann Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"933913","DOI":"10.3389\/fcvm.2022.933913","article-title":"Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis","volume":"9","author":"Ye","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1499449","DOI":"10.3389\/fcvm.2025.1499449","article-title":"Diagnostic and prognostic value of systemic immune-inflammation index for heart failure: a systematic review and meta-analysis","volume":"12","author":"Yu","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ehf2.14166","article-title":"Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction","volume":"10","author":"Witte","year":"2023","journal-title":"ESC Heart Fail"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1928233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:15Z","timestamp":1788412455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1928233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":50,"alternative-id":["10.3389\/fcvm.2026.1928233"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1928233","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1928233"}}